Eugene Gerner
12Patents
4h-index
17Co-inventors
57Inventor score
Filing activity: Nov 3, 1998 → May 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6258845A | DFMO and sulindac combination in cancer chemoprevention | Human Necessities | 19 | Expired |
| US9121852B2 | Carcinoma diagnosis and treatment, based on ODC1 genotype | Physics | 8 | Active |
| US8329636B2 | Carcinoma diagnosis and treatment, based on ODC1 genotype | Physics | 8 | Active |
| US9937141B2 | Carcinoma diagnosis and treatment, based on ODC1 genotype | Physics | 7 | Active |
| US10945981B2 | Methods for treating familial adenomatous polyposis | Human Necessities | 1 | Active |
| US10655183B2 | Carcinoma diagnosis and treatment based on ODC1 genotype | Chemistry; Metallurgy | 1 | Active |
| US6709858B1 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 1 | Expired |
| US10151756B2 | Predictive markers for polyamine inhibitor cancer therapies | Physics | 1 | Active |
| US7098191B2 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US10845366B2 | Predictive markers for polyamine inhibitor cancer therapies | Physics | 0 | Active |
| US7056897B2 | Inducible expression vectors and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
| US7285542B2 | Hyperthermic inducible expression vectors for gene therapy and methods of use thereof | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.